Table 1.
Baseline demographic characteristics of people receiving either ChAdOx1, BNT162b2 or mRNA-1273 vaccines or testing positive for SARS-CoV-2 virus (before or after vaccination), in England between 1 December 2020 and 24 August 2021. Data are presented as column % (counts)
| ChAdOx1 | BNT162b2 | mRNA-1273 | ChAdOx1 | BNT162b2 | mRNA-1273 | Positive SARS-CoV-2 test (amongst total vaccinated) | |
|---|---|---|---|---|---|---|---|
| One dose (at least) (n = 38,615,491) | Two doses (n = 32,095,748) | ||||||
| Total number of people | 20,615,911 | 16,993,389 | 1,006,191 | 19,754,224 | 11,972,733 | 368,791 | 3,028,867 |
| Sex | |||||||
| Women | 43.3 (8,918,403) | 42.6 (7,233,091) | 29.9 (300,567) | 43.3 (8,559,325) | 47.2 (5,650,542) | 33.9 (125,120) | 45.7 (1,385,137) |
| Men | 34.9 (7,191,428) | 31.8 (5,401,842) | 28.5 (286,893) | 34.9 (6,900,964) | 32.6 (3,906,666) | 26.4 (97,524) | 32.2 (974,389) |
| Not recorded | 21.9 (4,506,080) | 25.6 (4,358,456) | 41.6 (418,731) | 21.7 (4,293,935) | 20.2 (2,415,525) | 39.6 (146,147) | 22.1 (669,341) |
| Age | |||||||
| Mean age (s.d.) | 55.2 (14.8) | 47.8 (21.7) | 32.3 (9.4) | 55.4 (14.7) | 55.5 (20.4) | 39.6 (7.3) | 44.5 (17.8) |
| 16–29 years | 5.2 (1,064,443) | 25.2 (4,285,600) | 41.4 (416,982) | 5.0 (988,291) | 10.4 (1,244,710) | 6.9 (25,382) | 24.4 (738,170) |
| 30–39 years | 7.8 (1,598,406) | 23.2 (3,945,405) | 36.4 (366,327) | 7.6 (1,494,285) | 20.7 (2,475,091) | 43.8 (161,412) | 19.0 (574,710) |
| 40+ years | 87.1 (17,953,062) | 51.6 (8,762,384) | 21.2 (222,882) | 87.4 (17,271,648) | 68.9 (8,252,932) | 49.3 (181,997) | 56.6 (1,715,987) |
| Ethnicity | |||||||
| White | 55.5 (11,449,387) | 52.3 (8,887,419) | 40.1 (403,362) | 55.8 (11,019,453) | 57.8 (6,921,753) | 43.0 (158,719) | 52.6 (1,593,727) |
| Indian | 1.5 (319,328) | 1.7 (288,641) | 0.7 (7,406) | 1.5 (304,100) | 1.8 (217,910) | 0.8 (2,975) | 2.4 (72,852) |
| Pakistani | 1.0 (214,193) | 1.1 (183,917) | 0.7 (6,724) | 1.0 (191,755) | 0.9 (105,414) | 0.4 (1,474) | 2.1 (64,153) |
| Bangladeshi | 0.4 (81,004) | 0.4 (62,128) | 0.3 (3,287) | 0.4 (74,743) | 0.3 (34,927) | 0.2 (684) | 0.7 (21,585) |
| Other Asian | 0.7 (137,542) | 0.8 (134,649) | 0.7 (6,648) | 0.7 (129,169) | 0.8 (90,508) | 0.7 (2,488) | 1.1 (31,933) |
| Black Caribbean | 0.5 (99,666) | 0.4 (62,101) | 0.3 (2,734) | 0.5 (91,098) | 0.4 (47,767) | 0.2 (664) | 0.5 (14,152) |
| Black African | 0.7 (149,358) | 0.7 (115,282) | 0.6 (5,929) | 0.7 (134,635) | 0.6 (73,472) | 0.5 (1,679) | 0.9 (27,757) |
| Chinese | 0.3 (53,279) | 0.3 (43,014) | 0.3 (3,261) | 0.3 (51,338) | 0.3 (30,662) | 0.5 (1,691) | 0.2 (4,585) |
| Other ethnic group | 1.8 (366,361) | 1.9 (321,150) | 1.9 (19,313) | 1.7 (342,040) | 1.7 (208,462) | 1.8 (6,795) | 2.3 (69,725) |
| Ethnicity not recorded | 37.6 (7,745,793) | 40.6 (6,895,088) | 54.4 (547,527) | 37.5 (7,415,893) | 35.4 (4,241,858) | 52.0 (191,622) | 37.3 (1,128,398) |
| Number of doses | |||||||
| One dose only | 4.1 (835,832) | 29.5 (5,007,083) | 63.3 (637,335) | – | – | – | 25.1 (759,352) |
| Cardiac inflammation in the previous 2 yearsa | |||||||
| Previous myocarditis | <0.1 (1,840) | <0.1 (1,485) | <0.1 (56) | <0.1 (1,747) | <0.1 (1,220) | <0.1 (15) | <0.1 (451) |
| Previous pericarditis | <0.1 (1,849) | <0.1 (1,508) | <0.1 (31) | <0.1 (1,771) | <0.1 (1,285) | <0.1 (8) | <0.1 (346) |
| Previous cardiac arrhythmia | 2.6 (538,564) | 2.9 (500,295) | 0.3 (2,969) | 2.6 (505,794) | 3.9 (466,724) | 0.3 (1,005) | 3.1 (92,985) |
aTwo years before 1 December 2020